Objective: Occupational therapists working within acute neurosciences assume a primary role in the identification of upper-limb impairments, and to achieve this, they require measurement tools, which are sensitive to small changes in patient function. The purpose of this study was to examine the psychometric properties of a newly developed upper-limb assessment tool (ULAT) for acute neurological patients. Methods: Using a prospective study design, 30 patients with a confirmed neurological diagnosis completed the ULAT. Nonparametric statistics were then completed to examine the ULAT's reliability. Results: The ULAT exhibited strong intra-and inter-rater reliability and acceptable internal consistency across patients with various neurological diagnoses. Conclusion: Evidence of the ULAT's robust reliability supports its ongoing refinement and potential use in acute care neurological settings by occupational therapists.
Introduction
Within the acute patient phase, occupational therapy (OT) assessment of the neurological upper limb is primarily focused on the impairment level measures of function such as pain, range of movement, spasticity, and sensation (Trombly Latham & Radomski, 2007) . Clinicians typically use a range of assessment techniques across these impairment domains, the use of which varies within and between acute care settings. A frequent criticism is that the resulting assessment process is inconsistent, subjective, and not sensitive to small changes in patients' functional status and thus provides limited evidence on which to plan and evaluate therapeutic interventions (Stapleton & Galvin, 2005; Stapleton & McBrearty, 2009) .
In 2005e2006, an internal audit of OT neurological assessment procedures was completed at Monash Medical Centre (MMC), Clayton, Victoria, Australia. MMC is a large, acute-care, university-affiliated, teaching hospital within the Southern Health region of the Melbourne metropolitan area. The audit identified that a range of predominantly nonstandardised, clinical techniques were being used to assess upper-limb impairment and function of patients presenting with neurological diagnoses. In response, the MMC OT Neuroscience Team undertook a 12-month project to investigate best practise principles in relation to the upper-limb assessment of acute neurological patients (Corben, Downie, & Fielding, 2011) .
A comprehensive literature review was subsequently undertaken based on a theoretical framework developed by Rudman and Hannah (1998) and clinically significant impairment-focused criteria. The literature search identified a total of 10 upper-limb assessment tools (ULATs) that presented with varying and inconsistent levels of reported reliability and validity. The availability of sufficiently detailed assessment protocols for each tool was a mandatory requirement for inclusion, thus at this time, several well-known neurological assessments were excluded from our review, namely the Chedoke McMaster Stroke Assessment (Gowland et al., 1993) , Functional Test for the Hemiplegic Upper ExtremitydHong Kong version (Fong et al., 2004) , and Wolf Motor Function Test (Wolf et al., 2001) . Seven of the 10 assessment tools selected for critique targeted the subacute stages of neurological recovery: Action Research Arm Test (Yozbatiran, Der-Yerghiaian, & Cramer, 2008) , FugleMeyer Upper-limb (Croarkin, Danoff, & Barnes, 2004) , Motor Assessment Scale (Carr, Shephard, Nordholm, & Lynne, 1985) , Motor Club Assessment (Croarkin et al., 2004) , Motricity Index (Croarkin et al.; Wade, 1992) , Rivermead Motor Assessment (Croarkin et al.) , and Trunk Control Test (Wade). Additionally, five of the tools were specific only to the stroke patient groups: FugleMeyer Upper-limb (Croarkin et al.) , Motor Assessment Scale (Carr et al., 1985) , Motricity Index (Wade), Rivermead Motor Assessment (Croarkin et al.) , and Trunk Control Test (Wade).
To support this present research study, a further literature review of previously omitted assessment tools (Chedoke McMaster Stroke Assessment, Functional Test for the Hemiplegic Upper ExtremitydHong Kong version, and Wolf Motor Function Test) was subsequently undertaken. This review similarly demonstrated a focus on functional assessments that require whole of upper-limb use, often beyond the physical capability of acute neurological patients, and predominantly aimed at the stroke diagnostic groups.
A significant limitation of all assessment tools considered is thus a primary emphasis on motor performance at the exclusion of other clinically significant assessment criteria such as shoulder integrity, spasticity, sensation, and coordination. This finding clearly reinforces the need for an acutely focused ULAT; to facilitate the integration of evidence to clinical practice; and assist clinicians with goal planning, intervention provision, and program evaluation.
Although the literature search failed to identify a single assessment tool reflective of all elements of acute neurological practice, four standardised tools were identified as being potentially useful: Dynamometer (Mathiowetz, Weber, Vollaqnd, & Kashman, 1984; Wade, 1992) , Modified Ashworth Scale (Bohannon & Smith, 1987) , Motor Assessment Scale (Carr et al., 1985) , and Nine Hole Peg Test (Croarkin et al., 2004; Demeurisse, Demol, & Robaye, 1980) . Using the approach developed by Croarkin et al., two of these assessments were then selected to form the basis of a composite ULAT: the Motor Assessment Scale (Carr et al.) and the Modified Ashworth Scale (Bohannon & Smith) . To ensure the comprehensiveness of the ULAT, other significant neurological domains were also included as part of the assessment, including shoulder pain, shoulder integrity, passive range, spasticity, coordination, and sensation. Standardised assessment and scoring protocols for each of the domains were subsequently developed, formatted, and trialled. The upper-limb subsection of the Australian Therapy Outcome Measures for OT (AusTOMs-OT; Unsworth & Duncombe, 2004) was also included as a qualitative measure of upper-limb functional use.
Administration guidelines for the ULAT were formatted, field tested, and revised. Extensive staff training was then conducted as to the administration of the ULAT, which was trialled across three Southern Health acute-care sites: MMC, Dandenong Hospital, and Casey Hospital. Clinicians involved in the trial then completed an evaluation questionnaire to establish clinical utility of the ULAT. Feedback from the trial clinicians was significantly positive and indicated that the ULAT fulfilled a number of previously unmet clinical needs (Corben et al., 2011) .
This article provides further information on the development of the ULAT in relation to its reliability, with the aim of supporting its further refinement and clinical use with acute neurological patients. Reliability refers to the consistency of a set of measures over time (Polgar & Thomas, 2008) . The use of clinical assessments with proven reliability is essential in ensuring that changes in patient condition and/or function are related to observable differences as opposed to the influence of other extraneous variables (DePoy & Gitlin, 1994) . Thus, the purpose of the article is to examine the ULAT's reliability and specifically investigate its intra-, inter-rater reliability, and internal consistency.
Methods

Study Design
A prospective reliability study was chosen to guide the formal trial of the ULAT. Data collection was completed in a single phase, with a target sample size set at 20 participants for both intra-and inter-rater reliability analyses.
Participants
Eligible participants were acute neurological inpatients consecutively admitted to MMC with a confirmed neurological diagnosis. MMC is a large metropolitan, tertiary health care facility affiliated with Monash University, Victoria, Australia, located within southern metropolitan Melbourne.
Inclusion criteria for participants were defined as age of 18 years or older, a formal neurological diagnosis, patient/ next of kin consent, and an ability to tolerate the completion of the full upper-limb assessment. Participants with concurrent medical diagnoses, which may have impacted on their cognitive ability to complete the assessment, were excluded from the study cohort (i.e., dementia, receptive dysphasia, significant intellectual disability, and reduced alertness). Diagnoses, such as epilepsy, which may present with pseudolimb weakness (i.e., Todd's paresis), were also excluded from participation.
Instrumentation
The study involved trials of the ULAT for acute neurological patients (as outlined above), administered by a MMC OT staff member as part of their standard clinical assessment. Initially developed in 2007 by the MMCdOT Neurosciences Team (Corben et al., 2011) , the ULAT consists of two standardised assessments (the Motor Assessment Scale [Carr et al., 1985] and the Modified Ashworth Scale [Bohannon & Smith, 1987] ) and several qualitative neurological domains assigned a quantitative score, including the AusTOMs-OT upper-limb subsection (Unsworth & Duncombe, 2004 ; see Appendix 1).
The ULAT is comprised of 30 individual test items that are grouped into eight assessment domains or subscales; shoulder integrity, passive range of movement (PROM), tone, spasticity, active range of movement (AROM), sensation, coordination, and AusTOMs-OT (see Appendix 2).
These domains also formed the basis for this study's analysis of the ULAT's reliability. The ULAT can only be administered by a qualified occupational therapist and takes approximately 30 min to complete.
Procedure
Formal ethics approval for this research study was gained from Southern Health's Human Research Ethics Committee B. Informed consent for participant involvement and medical records access was also obtained from individual patients and/or their next of kin, as per the Health Records Act 2001 (Victoria; Skene, 2004) . Eligible participants were recruited by an independent member of the research team to take part in the study. The principle investigator then collected basic demographic data from the participant's medical record (i.e., age, sex, neurological diagnosis, hand dominance, and affected upper limb). Length of stay data were calculated on each participant's discharge from the acute ward.
As per standard clinical practice, each participant was allocated to a primary treating occupational therapist who completed the preliminary ULAT as a part of the Note. P22 was withdrawn from study as they were discharged to a rehabilitation facility before the upper-limb assessment tool assessment could be completed. UL Z upper limb.
participant's initial OT assessment. Before the commencement of the trial, all OT staff received extensive practical training in the administration of the ULAT from the author to ensure uniformity of practice. Readministration of the ULAT for the purposes of intra-rater reliability was limited to within 36 hours of the initial ULAT assessment, whereas inter-rater reliability was limited to within 48 hours. A total of 30 participants were recruited for this study. The aim was to collect both intra-and inter-rater reliability data for the ULAT from each of the 30 individual participants; however, this proved to be achievable for only half (n Z 15) of the sample. Intra-and inter-rater reliability data collection was completed for a total of 21 and 24 participants, respectively, with the reliability data then combined for internal consistency analysis. Final data collection thus exceeded recruitment targets for the study, as outlined above.
Data Entry, Management, and Analysis
Data collection, management, and storage were conducted in accordance with the Commonwealth Privacy Act-1988 (Skene, 2004) 
Results and Discussion
Participant Demographics
Thirty-one acute inpatients (male: 22 and female: 9) presenting with a neurological diagnoses met the eligibility criteria for the study. The age of study cohort ranged from 30 years to 88 years (mean Z 64 years) and most commonly presented with a primary neurological diagnosis of stroke (n Z 21). Ninety percent of the participants were reported as being right hand dominant (n Z 27). The left upper limb was the more commonly affected in a postneurological event (n Z 18), in comparison with the right upper limb (n Z 7) or bilateral upper limbs (n Z 5). Participants were assessed at varying points in their acute-care inpatient stay, from the day of admission to the day of discharge. Eleven days was the average length of stay for the study participants, ranging from 1 inpatient day to 103 inpatient days (Table 1) .
Intra-rater Reliability
Intra-rater reliability analyses for the ULAT were based on data collected from 21 of the 30 study participants. Using SPSS, Spearman's rho and Kendall's tau correlation coefficients were calculated for each of the ULAT's assessment domains at Time 1 administration versus Time 2 administration to indicate the degree to which the ULAT is likely to provide consistent results if administered on two or more occasions by the same rater. For the left upper limb, both the Spearman's rho and Kendall's tau statistical analyses indicated excellent intra-rater reliability across all ULAT assessment domains (Table 2) . Correlation coefficients for the ULAT's assessment domains ranged from r Z .88 to r Z 1.00, all at a statistical significance of p value less than .001. In comparison, correlation coefficients for right ULAT assessment domains were more varied (Table 3) . Perfect correlations were obtained for the domains of shoulder, tone, AROM, and AusTOMs-OT (r Z 1.00, p < .001). Intrarater reliability coefficients were also within the excellent range for PROM (r Z .88, p < .001), with moderate correlations found for both spasticity (r Z .65, p Z .004 Kendall's tau, p < .001 Spearman's rho) and coordination assessment domains (r Z .59 Kendall's tau, r Z .62 Spearman's rho, p Z .003). Although a low correlation coefficient (Fong et al., 2004) r Z .93, p < 0.01 for both test procedures and functional level scores (Fong et al.) .
Modified Ashworth Scale Brain damage (intrarater) & intracranial lesions (inter-rater)
Kappa r Z .47e.62 for combined upper/lower limb spasticity (Mehrholz et al., 2005) r Z .85, p < .001 for elbow (Bohannon & Smith, 1987) Motor (Table 4 ).
In examining the reduced strength of correlations for right upper-limb spasticity, coordination, and sensation domains, these outcomes may be associated with the study's relatively small sample size and thus insufficient statistical power to detect a significant result. An alternate clinical hypothesis for these results is that the variability in right upper-limb correlations could also potentially reflect progression in patient neurological impairments, even within the 36-hour time limit for intra-rater assessment. This may be likely given that spasticity, sensation, and coordination can alter dramatically within the first several days of postacute neurological event (Bogousslavsky & Castillo, 1997) .
Inter-rater Reliability
Of the 30 study participants, 24 contributed data for the purpose of inter-rater reliability analyses of the ULAT. SPSS was again used to calculate Spearman's rho and Kendall's tau correlation coefficients for each of the ULAT's assessment domains at Time 1 (Clinician A) versus Time 2 (Clinician B), to indicate the degree to which the ULAT is likely to provide consistent results if administered on multiple occasions by different raters or clinicians. Very strong correlations were obtained across all left-sided ULAT domains ranging from .81e1.00 (p < .001), indicating very good inter-rater reliability (Table 5 ). However, the assessment domain of AROM was the only perfect correlation coefficient obtained (r Z 1.00, p < .001).
Similar to the results for intra-rater reliability, the ULAT's inter-rater reliability coefficients were more varied when assessing the right upper-limb assessment domains (Table 6) . Very strong inter-rater reliability was recorded for the domains of tone, sensation, and AusTOMs-OT, with coefficients ranging from r Z .87 to r Z 1.00 (p < .001). Several statistically significant, moderate correlations were also obtained for shoulder (r Z .72, p Z .001 Kendall's tau, p < .001 Spearman's rho), spasticity (r Z .62, p Z .003 Kendall tau, p < .001 Spearman's rho), AROM (r Z .62, p Z .003 Kendall's tau, p < .001 Spearman's rho), and coordination (r Z .67 Kendall's tau, r Z .73 Spearman's rho, p < .001). A negative correlation coefficient was obtained for the PROM assessment domain, indicating an inverse relationship between the assessment of joint passive range by two independent clinicians. However, this relationship was not statistically significant (p Z .42 Kendall's tau, p Z .44 Spearman's rho).
Rivermead Motor Assessment
Stroke r Z .88 for arm subscales (Lincoln & Leadbitter, 1979) Significant difference reported across raters of arm subscale ( (Nijland et al., 2010; Whitall, Savin, Harris-Love, & Waller, 2006) ICC Z .93e.99 (Morris et al., 2001; Nijland et al.; Whitall et al., 2006; Wolf et al., 2001) Note. ABI Z acquired brain injury; ICC Z intraclass correlation coefficient.
In the context of an acute neurological patient group, both the Kendall's tau and Spearman's rho statistical analyses indicate the ULAT's inter-rater reliability to overall be within the good to very good range. Again this result is largely comparable with the documented interrater reliability of other commonly used neurological upper-limb assessments (Table 4 ). Owing to differences in clinical expertise and judgement between therapists, a degree of variability was not to be unexpected between raters. However, what is unusual is that the statistical results indicate variability to be limited to assessment of the right upper limb. Given that a similar trend was also observed for intra-rater reliability analysis, it is hypothesised that this result may be more reflective of changes in patient neurological status occurring within the study cohort during the 48-hour assessment window. This is particularly likely given that the intra-and inter-rater reliability samples share 15 common participants.
Internal Consistency
Data from the assessment of all study participants at Time 1 (n Z 30) was used to calculate the internal consistency of the eight individual assessment domains or subscales of the ULAT; shoulder, PROM, tone, spasticity, AROM, sensation, coordination, and AusTOMs-OT. Cronbach's alpha coefficients were calculated using SPSS to demonstrate how reliably the individual assessment domains reflect the overall idea or construct of the ULAT assessment. Analyses were separately completed for ULAT use with the left upper limb, right upper limb, and both upper limbs across the eight assessment domains. For each of these three analyses, Cronbach's alpha coefficients approached a moderate reliability level (i.e., .70); left upper limb (a Z .66), right upper limb (a Z .69), and both upper limbs (a Z .59). In the context of this preliminary research study, achieving Cronbach's alpha coefficients of approximately .6 suggests that the individual ULAT assessment domains are somewhat reflective of its wider construct of acute neurological impairment. It also indicates that the ULAT's items are likely to be moderately correlated with each other. This is consistent with the clinical basis of the assessment, with seven of the eight assessment domains considered to be impairment-focused. The exception to this is the AusTOMs-OT, which is based on the World Health Organisation's (2001) International Classification of Functioning, Disability and Health; impairment, activity limitation participation restriction, and well-being.
Limitations and Recommendations
There are several limitations inherent in this study, which may have impacted on the results obtained. Slower than anticipated participant recruitment and project time constraints necessitated the revision of the original scope of the project. Sample size targets were subsequently reduced, which may have adversely impacted on the statistical power needed to detect a significant result. A sample of convenience was also used to recruit the participant group from a single health care facility, which also limits external validity.
Despite obtaining good to excellent statistically significant reliability coefficients, clinician feedback arising from the project suggested that further revision of the ULAT is warranted to improve its sensitivity for an acute neurological population. All clinicians involved in the trial reported that they felt that the AROM assessment domain, which incorporates the Motor Assessment ScaledAdvanced Hand Activities assessment (Croarkin et al., 2004) , to be insensitive to subtle changes in active range within this patient population. This may potentially have positively skewed the results obtained for both intra-and inter-rater reliability pertaining to the AROM domain. Clinicians also reported some confusion as to how to score the AusTOMs-OT assessment domain for affected and nonaffected limbs respectively, given that three of the four AusTOMs-OT criteria (activity limitation, participation restriction, and well-being) are measures of bilateral hand use in the context of functional activity. Although excellent reliability correlation coefficients were obtained for the AusTOMs-OT assessment, differences in interpretation of scoring may have influenced the statistical results obtained. Thus, the AusTOMs-OT assessment protocol may benefit from further revision to improve the clarity of scoring instructions for assessors and in turn reliability. As the AusTOMs-OT is a copyrighted instrument, any changes in scoring would need to be completed in consultation with the authors.
Following these minor revisions, larger research trials are recommended to further examine the ULAT's validity and the generalisability of the assessment across both clinicians and external acute-care settings.
Conclusion
This pilot study examined the reliability of a newly developed assessment tool for acute neurological patients, the ULAT, to support its further development and clinical use. From the statistical results obtained, the ULAT appears to have good to excellent intra-rater reliability and good to very good inter-rater reliability, when administered to patients with various acute neurological diagnoses and associated left, right, or bilateral upper-limb dysfunction. Internal consistency findings also suggest that the eight individual assessment domains of the ULAT are somewhat reflective of the ULAT's wider construct of neurological upper-limb impairment. Evidence of the ULAT's robust intra-or inter-rater reliability and adequate internal consistency would appear sufficient to support its ongoing trial and refinement within the clinical setting. However, the need for further research trials with larger sample sizes and across multiple acute-care settings is strongly recommended to further examine the ULAT's validity. AusTOMS-OT impairment AusTOMS-OT 28
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AusTOMS-OT well-being Note. AROM Z active range of movement; AusTOMS-OT Z Australian Therapy Outcome Measures for Occupational Therapy; PROM Z passive range of movement; ULAT Z upper-limb assessment tool.
